A Comparative Analysis of Pricing and Reimbursement of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Europe

Objectives: Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, Kalydeco® (ivacaftor), Orkambi® (lumacaftor/ivacaftor) and Symkevi® (tezacaftor/ivacaftor), have substantially improved patients’ lives yet significantly burden healthcare budgets. This analysis aims to compare pricin...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdallah, Khadidja, De Boeck, Kris, Dooms, Marc, Simoens, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630624/
https://www.ncbi.nlm.nih.gov/pubmed/34858177
http://dx.doi.org/10.3389/fphar.2021.746710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630624/
https://www.ncbi.nlm.nih.gov/pubmed/34858177
http://dx.doi.org/10.3389/fphar.2021.746710

Ejemplares similares